- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
< Back to Bio
Alison Elizabeth Pearman
View all
Alison Elizabeth Pearman
News 7 results
Press Release
December 9, 2025
King & Spalding Elects 27 Partners and 17 Counsel for 2026
In the News · Source: Law360 Pulse, Daily Report, ABF Journal, The Deal, Le Monde du Droit, Décideurs Magazine, La Lettre des Juristes d'Affaires,The Oath, Legal Era, Commercial Dispute Resolution, Connect CRE, CRE MarketBeat, Global Legal Chronicle, The Drawdown, Atlanta Business Chronicle, Texas Lawyer, The Texas Lawbook, Global Arbitration Review, Le Journal du Dimanche, Les Echos Capital Finance, Thomson Reuters Westlaw Today and VDCommunication
December 9, 2025
K&S elects 27 new partners and promotes 17 counsel across 13 offices
In the News · Source: Law360 Real Estate Authority
October 28, 2024
David Ridenour, Kevin Gilroy, Alison Pearman, Yoojin Lee, Rosie Watterson, Jonathan Arkins and John Green counsel Cologix on its $1.5B fundraise
Cases & Deals
October 17, 2024
King & Spalding Advises Cologix, Inc. on $1 Billion Financing
Insights 1 results
Article · Source: Chambers and Partners
April 29, 2025
Debt Finance 2025 (USA – Washington, DC)